Search Results
Mar 18, 2026, 10:15 ET Significant U.S. Uranium Deposit Advances with Permitting Team NUCL, CCJ, UEC, SMR, and NXE as Uranium Demand Meets Domestic Supply Urgency
not limited to, (i) market risks; (ii) the outcome of any legal proceedings that may be instituted against Eagle related to its business combination; (iii) failure to realize the anticipated benefits of the business combination; (iv) the inability to maintain the listing of the Company's securities on Nasdaq
More news about: Equity Insider
Mar 18, 2026, 09:15 ET Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
our partners' ability to deploy new products, services, and applications, and to expand the markets for genomics-related products and services; and (iii) the challenges associated with multiparty collaborations, including our reliance on the performance of such partners, together with other factors detailed
More news about: Illumina, Inc.
Mar 18, 2026, 09:14 ET Phanes Therapeutics to Present Three Clinical Posters at AACR 2026
American Association for Cancer Research (AACR) held on April 17-22 in San Diego, CA. All three posters will be presented under the Phase II and Phase III Clinical Trials Session. Details of each presentation are below:
More news about: Phanes Therapeutics, Inc.
Mar 18, 2026, 09:00 ET Class Action Filed Against Plug Power Inc. (PLUG) Seeking Recovery for Investors - Contact Levi & Korsinsky
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a
More news about: Levi & Korsinsky, LLP
Mar 18, 2026, 09:00 ET Shareholders that lost money on Beyond Meat, Inc.(BYND) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the SEC; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss
More news about: Levi & Korsinsky, LLP
Mar 18, 2026, 09:00 ET Aspen Neuroscience Announces Positive 12‑Month Data from its ASPIRO Clinical Trial in a Late‑Breaking Oral Presentation at the AD/PD™ 2026 International Conference on Alzheimer's and Parkinson's Diseases
patient-reported outcomes, and quality-of-life, including: mean Good ON time (+2.1 hours in low dose (LD), +2.4 hours in high dose (HD)), mean MDS-UPDRS III OFF scores (-15.5 points in LD, -13.5 points in HD), mean MDS-UPDRS II scores (-5.3 points in LD, -2.3 points in HD), and mean improvement in PDQ-39
More news about: Aspen Neuroscience, Inc.
Mar 18, 2026, 08:30 ET SM ENERGY ANNOUNCES EARLY TENDER RESULTS; EXTENDS AND UPSIZES PREVIOUSLY ANNOUNCED CASH TENDER OFFER
aggregate principal amount not to exceed $1,000,000,000 (as modified, and as it may be further modified by SM Energy, the "Maximum Tender Amount"), and (iii) the extension of the Early Tender Premium (as defined below) until the Expiration Date (as defined below), each subject to the terms and conditions
More news about: SM Energy Company
Mar 18, 2026, 08:00 ET Spinal Elements Expands Ventana® Platform with FDA 510(k) Clearance and First Cases of Ventana® A ALIF System
partners to develop systems that are meaningfully differentiated and deliver improved outcomes".The first case was performed by Dr. A.J. Rush III at Texas Spine Consultants in Addison, TX. Dr. Rush shared: "The Ventana A system delivers a clinical advantage to everyday challenges for spine surgeons.
More news about: Spinal Elements
Mar 18, 2026, 08:00 ET Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026
β-catenin antagonist, demonstrates safety and efficacy in metastatic colorectal cancer (mCRC)"Session Title: Phase II and Phase III Clinical TrialsLocation: Poster Section 52, Poster Board Number 20Abstract Number: CT156Date and Time:
More news about: Sapience Therapeutics, Inc.
Mar 18, 2026, 07:44 ET Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Type: Poster Session: Phase II and Phase III Clinical Trials in ProgressDate/Time: April 21, 2026, 9:00 a.m.-12:00
More news about: Jazz Pharmaceuticals plc
Mar 18, 2026, 06:45 ET Cohesity and ServiceNow Deliver Real-Time Recovery for Enterprise AI Agents
expenses in executing the partnership or delivering the product capabilities and offerings, (ii) changes in the regulatory landscape related to AI and (iii) uncertainty as to whether sales will justify the investments in the product capabilities and offerings. Further information on factors that could affect
More news about: Cohesity
Mar 18, 2026, 06:43 ET Cohesity and ServiceNow Deliver Real-Time Recovery for Enterprise AI Agents
expenses in executing the partnership or delivering the product capabilities and offerings, (ii) changes in the regulatory landscape related to AI and (iii) uncertainty as to whether sales will justify the investments in the product capabilities and offerings. Further information on factors that could affect
More news about: Cohesity
Mar 18, 2026, 05:00 ET Weibo Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Annual Dividend
loss of US$12.2 million in 2024; (ii) gain from fair value change of investments of US$21.3 million, which was excluded under non-GAAP measures; and (iii) investment related impairment of US$6.0 million, which was excluded under non-GAAP measures.Income tax expenses for 2025 were US$144.5 million,
More news about: Weibo Corporation
Mar 18, 2026, 03:05 ET Hello Group Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2025
(iii) Includes tax impacts related to the amortization of intangible assets from business acquisition. There is no tax impact related to share-based compensation.
More news about: Hello Group Inc.
Mar 18, 2026, 00:19 ET FRONTERA ANNOUNCES FOURTH QUARTER 2025, YEAR-END 2025 RESULTS AND RESERVES
including: (i) $0.9 million towards the connection project between Puerto Bahia's port facility and the Cartagena refinery, (ii) tank maintenance, and (iii) general expenditures related to the cargo terminal facilities. Fourth quarter capital expenditures also included investment in the SAARA project and
More news about: Frontera Energy Corporation
Mar 17, 2026, 18:00 ET ZTO Reports Fourth Quarter 2025 and Full Year 2025 Unaudited Financial Results
consisted of (i) RMB67.9 million (US$9.7 million) of rental income, (ii) RMB46.5 million (US$6.7 million) of government subsidies and tax rebates, and (iii) RMB24.1 million (US$3.4 million) ADR fee rebate.Income from operations was RMB3,189.4 million (US$456.1 million), decreased 7.6% from
More news about: ZTO Express (Cayman) Inc.
Mar 17, 2026, 18:00 ET 中通快遞發佈2025年第四季度及2025财政年度未經審計財務業績
非執行董事，以及董事會薪酬委員會主席兼成員、提名及公司治理委員會成員，自 2026年3月18日起生效。本公司對魏先生的貢獻表示誠摯謝意，並祝願他未來工作順利。董事會已委任 (i) Herman Yu先生為提名及公司治理委員會成員，(ii) 黃沁先生為提名及公司治理委員會主席，及 (iii) 謝芳女士為薪酬委員會主席。該等變更將於2026年3月18日起生效。前景展望根據目前的市場和運營情況，本公司2026年包裹量預期將在423.7億至435.2億之間，同比增長10%至13% 。該等估計代表管理層目前的初步看法，可能會發生變化。
More news about: 中通快遞（開曼）有限公司
Mar 17, 2026, 17:30 ET NuScale Power Corporation (SMR) Investors with Substantial Losses Have Opportunity to Lead Class Action
of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (iii) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience
More news about: Robbins Geller Rudman & Dowd LLP
Mar 17, 2026, 17:00 ET Contango Stockholders Overwhelmingly Approve Merger with Dolly Varden
patented mining claims located in the Willow Mining District about 75 miles north of Anchorage, Alaska, from the underlying owner, Alaska Hardrock Inc., (iii) mineral rights to approximately 145,000 acres of State of Alaska mining claims, and (iv) mineral rights to approximately 11,700 acres of State of Alaska
More news about: Contango Ore
Mar 17, 2026, 16:54 ET Bitmine Immersion Technologies (BMNR) maakt bekend dat het 4,596 miljoen ETH-tokens in bezit heeft en dat het totale bezit aan cryptovaluta en contanten 11,5 miljard dollar bedraagt
Bitmine wordt ondersteund door een vooraanstaande groep institutionele investeerders, waaronder Cathie Wood van ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital en persoonlijke investeerder Thomas 'Tom' Lee om het doel van Bitmine om 5% van ETH te verwerven te ondersteunen.
More news about: Bitmine Immersion Technologies, Inc.
Mar 17, 2026, 16:40 ET PLUG SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026
facilities necessary to receive those funds; (ii) as such, Plug Power was likely to pivot toward more modest projects with less commercial upside; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.On October 7, 2025, Plug Power issued
More news about: Faruqi & Faruqi, LLP
Mar 17, 2026, 16:35 ET Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
disease-free survival as determined by investigator, and the primary completion date is estimated to be in 2030. Nuvation Bio is also sponsoring TRUST-III (
More news about: Nuvation Bio Inc.
Mar 17, 2026, 16:34 ET LAKE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Lakeland (LAKE) Investors of Securities Class Action Deadline on April 24, 2026
these businesses on Lakeland's financial results, as well as the overall strength and quality of Pacific Helmets' and Jolly's respective operations; (iii) Lakeland's business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification
More news about: Faruqi & Faruqi, LLP
Mar 17, 2026, 16:25 ET INVESTOR ALERT: Eos Energy Enterprises, Inc. Investors with Substantial Losses Have Opportunity to Lead the Eos Energy Class Action Lawsuit
set guidance; (ii) Eos Energy's battery line downtime was running well above industry norms, the design intent of the line, and internal forecasts; (iii) Eos Energy was experiencing delays in the ability for its automated bipolar production to hit quality targets; and (iv) Eos Energy's inadequate systems
More news about: Robbins Geller Rudman & Dowd LLP
Mar 17, 2026, 16:10 ET YY Group Announces Strategic Investment in Arros AI, an NVIDIA Inception Program Member
forward-looking statement. These factors include, but are not limited to, (i) growth of the hospitality market (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited